Neuroendocrine regulation of cholangiocarcinoma: A status quo review

Biochim Biophys Acta Rev Cancer. 2019 Aug;1872(1):66-73. doi: 10.1016/j.bbcan.2019.05.005. Epub 2019 May 30.

Abstract

Increasing studies have demonstrated that neuroendocrine system is involved in the development and progression of cholangiocarcinoma. The neuroendocrine hormones, neurotransmitters and neuropeptides regulate cholangiocarcinoma via affecting pathophysiology of tumor cells. The developing interaction and interplay between neuroendocrine-associated factors and tumor cells provide novel insights into neural control of tumorigenesis and reveal potential therapeutic effect on patients with cholangiocarcinoma. Herein we reviewed the latest findings and achievements which demonstrate the close interactions between neuroendocrine regulation and progression of cholangiocarcinoma. Also, future therapeutic approaches targeting neuroendocrine-associated factors are discussed which may help improve management and treatment of cholangiocarcinoma.

Keywords: Cholangiocarcinoma; Neuroendocrine hormones; Neuroendocrine regulation; Neuropeptides; Neurotransmitter.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Cholangiocarcinoma / genetics*
  • Cholangiocarcinoma / pathology
  • Humans
  • Liver Neoplasms / genetics*
  • Liver Neoplasms / pathology
  • Neuropeptides / genetics
  • Neuropeptides / metabolism
  • Neurosecretory Systems / metabolism*
  • Neurosecretory Systems / pathology
  • Neurotransmitter Agents / genetics
  • Neurotransmitter Agents / metabolism

Substances

  • Neuropeptides
  • Neurotransmitter Agents